Skip to main content
Download PDF

Correction to: New approaches to symptomatic treatments for Alzheimer’s disease

Molecular Neurodegeneration volume 16, Article number: 21 (2021) Cite this article

The Original Article was published on 13 January 2021

Correction to: Mol Neurodegeneration 16, 2 (2021)

https://doi.org/10.1186/s13024-021-00424-9

The original article [1] contains an error in the spelling of Masupirdine.

All instances of ‘Masuperdine’ should thus be considered as ‘Masupirdine’.

Reference

  1. Cummings J. New approaches to symptomatic treatments for Alzheimer’s disease. Mol Neurodegeneration. 2021;16:2 https://doi.org/10.1186/s13024-021-00424-9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Brain Health, School of Integrated Health Sciences, University of Nevada Las Vegas, Las Vegas, NV, USA

    Jeffrey Cummings

Authors
  1. Jeffrey Cummings
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jeffrey Cummings.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cummings, J. Correction to: New approaches to symptomatic treatments for Alzheimer’s disease. Mol Neurodegeneration 16, 21 (2021). https://doi.org/10.1186/s13024-021-00446-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13024-021-00446-3

Molecular Neurodegeneration

ISSN: 1750-1326